| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes |  | | 2024 | 371 | 3 |
|
| Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes | Biochimica et biophysica acta. G, General subjects | | | 2023 | 101 | 0 |
|
| Circulating 1,5-anhydroglucitol as a biomarker of ß-cell mass independent of a diabetes phenotype in human subjects | The Journal of clinical endocrinology and metabolism | | | 2022 | 424 | 2 |
|
| In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way | Journal of Biological Chemistry |  | | 2019 | 464 | 177 |
|
| Reply to Mishra: prohibitin heterodimers—a complex time dependence for carcinogenesis | Journal of Biological Chemistry | | | 2019 | 320 | 148 |
|
| Metabolomics identifies a biomarker revealing in vivo loss of functional ß-cell mass before diabetes onset | Diabetes | | | 2019 | 397 | 1,090 |
|
| Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis | Diabetes | | | 2018 | 419 | 1,596 |
|
| Mitochondrial function and morphology in prohibitin 2 deleted ß-cells and hepatocytes | | | | 2017 | 816 | 13 |
|
